Induction of apoptosis by IFNγ in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit

被引:0
|
作者
Francesca Bernassola
Christian Scheuerpflug
Ingrid Herr
Peter H Krammer
Klaus-Michael Debatin
Gerry Melino
机构
[1] IDI-IRCCS,Department of Hematology/Oncology
[2] Biochemistry Lab,undefined
[3] c/o University of Rome Tor Vergata,undefined
[4] University Children's Hospital,undefined
[5] Tumour Immunology Program,undefined
[6] German Cancer Research Center,undefined
来源
关键词
cell death; apoptosis; IFNγ; neuroblastoma; CD95 (APO-1, Fas);
D O I
暂无
中图分类号
学科分类号
摘要
The CD95 (APO-1/Fas) system can mediate apoptosis in immune cells as well as in tumour cells, where it may contribute to tumour immune-escape. On the other hand, its induction by anticancer drugs may lead to tumour reduction. Interferonγ (IFNγ) increases the sensitivity of tumour cell lines to anti-CD95 antibody-mediated apoptosis. We describe induction of apoptosis by IFNγ through the expression of CD95 and its ligand (CD95L) in human neuroblastoma cell lines. Neuroblastoma cells showed low constitutive expression of CD95 and CD95L. Subsequent to IFNγ-modulated increase in CD95 and CD95L mRNA as well as protein levels, apoptosis was observed. Our results demonstrated that cytokine-mediated apoptosis was mediated through the activation of the CD95/CD95L autocrine circuit since: (i) cell death occurred following CD95/CD95L expression and correlated with CD95 and CD95L expression levels, (ii) failed to occur in a clone which weakly upregulated CD95 and lacked CD95L induction after IFNγ stimulation, (iii) was at least partially inhibited by using blocking F(ab′)2 anti-CD95 antibody fragments and the recombinant Fas-Fc protein, that prevented the interaction between CD95 and CD95L. The intracellular molecular mechanisms elicited by IFNγ are clearly highly complex, with several signalling pathways being activated, including the CD95 system. These findings suggest that IFNγ may have a significant potential in the therapy of neuroblastoma in vivo.
引用
收藏
页码:652 / 660
页数:8
相关论文
共 50 条
  • [31] Glucocorticoids induce apoptosis in monocytes from IBD patients involving the CD95/CD95L pathway.
    Kucharzik, T
    Schmidt, M
    Luegering, N
    Luegering, A
    Schulze-Osthoff, K
    Pauels, HG
    Domschke, W
    GASTROENTEROLOGY, 2000, 118 (04) : A347 - A347
  • [32] CD95L
    Yagita, H
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2000, 14 (02): : 130 - 132
  • [33] Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma
    Glick, RD
    Swendeman, SL
    Coffey, DC
    Rifkind, RA
    Marks, PA
    Richon, VM
    La Quaglia, MP
    CANCER RESEARCH, 1999, 59 (17) : 4392 - 4399
  • [34] Upregulation of Fas/FasL (CD95/CD95L)-mediated epithelial apoptosis: a novel therapeutic target in pouchitis
    Coffey, JC
    Bennett, MW
    Wang, JH
    Neary, P
    O'Connell, J
    Shanahan, F
    Redmond, HP
    Kirwan, WO
    BRITISH JOURNAL OF SURGERY, 2001, 88 (05) : 756 - 756
  • [35] Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases
    Risso, Vesna
    Lafont, Elodie
    Le Gallo, Matthieu
    CELL DEATH & DISEASE, 2022, 13 (03)
  • [36] Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases
    Vesna Risso
    Elodie Lafont
    Matthieu Le Gallo
    Cell Death & Disease, 13
  • [37] Potentiation of CD95L-induced apoptosis of human malignant glioma cells by topotecan involves inhibition of RNA synthesis but not changes in CD95 or CD95L protein expression
    Winter, S
    Weller, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 286 (03): : 1374 - 1382
  • [38] Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L
    Sigel, JE
    Hsi, ED
    MODERN PATHOLOGY, 2000, 13 (04) : 446 - 451
  • [39] Irradiation induced clonogenic cell death of human malignant glioma cells does not require CD95/CD95L interactions
    Streffer, JR
    Schuster, M
    Pohl, U
    Belka, C
    Dichgans, J
    Bamberg, M
    Weller, M
    ANTICANCER RESEARCH, 1999, 19 (6B) : 5265 - 5269
  • [40] Carboxy-terminal domain of CD95 suppresses anti-CD95 antibody mediated but not CD95L mediated
    Thilenius, ARB
    Russell, JH
    FASEB JOURNAL, 1996, 10 (06): : 408 - 408